NCT00823238View on ClinicalTrials.gov

Comparison of Antibiotics for Pseudomonas in Early CF

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Cystic Fibrosis
Interventions
DRUG

ceftazidime and tobramycin

DRUG

inhaled tobramycin

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT00823238 - Comparison of Antibiotics for Pseudomonas in Early CF | Biotech Hunter | Biotech Hunter